Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | AHR | P35869 | 7/20 | 0.46 |
| ▸ | TTR | P02766 | 3/20 | 0.43 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.41 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.40 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.40 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.40 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.40 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | TNKS | O95271 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22315719 | 0.97 | IDO1 (0.50) | IDO1AHRTTRPSMB8PSMB5 | |
| SCHEMBL31672685 | 0.97 | IDO1 (0.50) | IDO1AHRTTRPSMB8PSMB5 | |
| SCHEMBL22284813 | 0.85 | PIM1 (0.49) | IDO1AHRTTRPSMB8PSMB5 | |
| SCHEMBL13564568 | 0.81 | IDO1 (0.42) | IDO1AHRPIM1CSNK2A2CSNK2B | |
| SCHEMBL18347519 | 0.79 | IDO1 (0.46) | IDO1TDO2TNKSCA1CA2 | |
| SCHEMBL29623029 | 0.79 | IDO1 (0.40) | IDO1TDO2TNKSCA1CA2 | |
| SCHEMBL21339985 | 0.77 | AHR (0.53) | AHRTTRPIM1CSNK2A2CSNK2B | |
| SCHEMBL29693277 | 0.77 | IDO1 (0.51) | IDO1AHRTTRPIM1CSNK2A2 | |
| SCHEMBL548396 | 0.75 | IDO1 (0.45) | IDO1AHRTDO2TNKSCA1 | |
| SCHEMBL31355173 | 0.74 | IDO1 (0.36) | IDO1TDO2TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250063936-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-02-20 | — | — | US | disclosed |
| US-20250034189-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034189-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, LEF1 | IDO1 3107/4885AHR 2029/4885TTR 3582/4885 |
| US-20250063936-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OPRM1 | IDO1 587/4885AHR 3383/4885TTR 1513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.